Lamisil® 250 mg Tablets

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA

Conditions

Healthy

Phase 1

Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions

CompletedNCT00833664

Teva Pharmaceuticals USAHealthy

Start: 2002-01-31End: 2002-01-31Updated: 2023-05-30

Terbinafine HCl 250 mg Tablet Under Fasting Conditions

CompletedNCT00833586

Teva Pharmaceuticals USAHealthy

Start: 2002-01-31End: 2002-01-31Updated: 2024-08-19